524 related articles for article (PubMed ID: 19124423)
1. Atrial fibrillation and renin-angiotensin system.
Serra JL; Bendersky M
Ther Adv Cardiovasc Dis; 2008 Jun; 2(3):215-23. PubMed ID: 19124423
[TBL] [Abstract][Full Text] [Related]
2. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.
Makkar KM; Sanoski CA; Spinler SA
Pharmacotherapy; 2009 Jan; 29(1):31-48. PubMed ID: 19113795
[TBL] [Abstract][Full Text] [Related]
3. Blockade of renin-angiotensin system: a supplementary treatment for circumferential pulmonary vein isolation in treating persistent atrial fibrillation.
Dai SM; Zhang S; Chu JM; Guo YH; Chen KP; Yao Sy
Med Hypotheses; 2007; 69(4):767-72. PubMed ID: 17475415
[TBL] [Abstract][Full Text] [Related]
4. [The effect of inhibition of renin-angiotensin system on cardioversion success and recurrences of atrial fibrillation].
Doğan A; Akçay S
Anadolu Kardiyol Derg; 2009 Dec; 9(6):505-11. PubMed ID: 19965325
[TBL] [Abstract][Full Text] [Related]
5. Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation.
Casaclang-Verzosa G; Gersh BJ; Tsang TS
J Am Coll Cardiol; 2008 Jan; 51(1):1-11. PubMed ID: 18174029
[TBL] [Abstract][Full Text] [Related]
6. Focus on renin-angiotensin system modulation and atrial fibrillation control after GISSI AF results.
Durin O; Pedrinazzi C; Inama G
J Cardiovasc Med (Hagerstown); 2010 Dec; 11(12):912-8. PubMed ID: 20729747
[TBL] [Abstract][Full Text] [Related]
7. Reviewing the future of renin-angiotensin system blockade: the role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the prevention of atrial fibrillation.
Ducharme A; Schiffrin EL
Can J Cardiol; 2010 Dec; 26 Suppl E():21E-23E. PubMed ID: 21620287
[TBL] [Abstract][Full Text] [Related]
8. The role of renin angiotensin system blockade in the treatment of atrial fibrillation.
Dilaveris P; Giannopoulos G; Synetos A; Stefanadis C
Curr Drug Targets Cardiovasc Haematol Disord; 2005 Oct; 5(5):387-403. PubMed ID: 16248831
[TBL] [Abstract][Full Text] [Related]
9. The renin-angiotensin system: a therapeutic target in atrial fibrillation.
Patlolla V; Alsheikh-Ali AA; Al-Ahmad AM
Pacing Clin Electrophysiol; 2006 Sep; 29(9):1006-12. PubMed ID: 16981926
[TBL] [Abstract][Full Text] [Related]
10. Prevention of new-onset atrial fibrillation and its predictors with angiotensin II-receptor blockers in the treatment of hypertension and heart failure.
Aksnes TA; Flaa A; Strand A; Kjeldsen SE
J Hypertens; 2007 Jan; 25(1):15-23. PubMed ID: 17143167
[TBL] [Abstract][Full Text] [Related]
11. The role of renin-angiotensin system blockade therapy in the prevention of atrial fibrillation: a meta-analysis of randomized controlled trials.
Zhang Y; Zhang P; Mu Y; Gao M; Wang JR; Wang Y; Su LQ; Hou YL
Clin Pharmacol Ther; 2010 Oct; 88(4):521-31. PubMed ID: 20811347
[TBL] [Abstract][Full Text] [Related]
12. Role of renin-angiotensin system inhibitors in atrial fibrillation.
Disertori M; Latini R; Maggioni AP
J Cardiovasc Med (Hagerstown); 2011 May; 12(5):374; author reply 375. PubMed ID: 21451337
[No Abstract] [Full Text] [Related]
13. Inefficiency of renin-angiotensin inhibitors in preventing atrial fibrillation in patients with a normal heart.
Fazio G; Pizzuto C; Sutera L; Guttilla D; Di Gesaro G; Cascio C; Novo G; Assennato P; Novo S
Minerva Cardioangiol; 2007 Jun; 55(3):311-5. PubMed ID: 17534249
[TBL] [Abstract][Full Text] [Related]
14. The impact of suppressing the renin-angiotensin system on atrial fibrillation.
Kalus JS; Coleman CI; White CM
J Clin Pharmacol; 2006 Jan; 46(1):21-8. PubMed ID: 16397280
[TBL] [Abstract][Full Text] [Related]
15. Direct pro-arrhythmogenic effects of angiotensin II can be suppressed by AT1 receptor blockade in human atrial myocardium.
von Lewinski D; Kockskämper J; Rübertus SU; Zhu D; Schmitto JD; Schöndube FA; Hasenfuss G; Pieske B
Eur J Heart Fail; 2008 Dec; 10(12):1172-6. PubMed ID: 18993115
[TBL] [Abstract][Full Text] [Related]
16. [Pathophysiology of the renin-angiotensin-system in atrial fibrillation].
Heusch G; Schulz R
Dtsch Med Wochenschr; 2006 Apr; 131(15):817-20. PubMed ID: 16607602
[TBL] [Abstract][Full Text] [Related]
17. Drug therapy for atrial fibrillation.
Conway EL; Musco S; Kowey PR
Cardiol Clin; 2009 Feb; 27(1):109-23, ix. PubMed ID: 19111768
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the renin-angiotensin system for prevention of atrial fibrillation.
Zografos T; Katritsis DG
Pacing Clin Electrophysiol; 2010 Oct; 33(10):1270-85. PubMed ID: 20636314
[TBL] [Abstract][Full Text] [Related]
19. Clinical trials, the renin angiotensin system and atrial fibrillation.
Birnie DH; Gollob M; Healey JS
Curr Opin Cardiol; 2006 Jul; 21(4):368-75. PubMed ID: 16755207
[TBL] [Abstract][Full Text] [Related]
20. [Non-antiarrhythmic pharmacological treatment of atrial fibrillation: focus on drugs acting on the renin-angiotensin system].
Durin O; Pedrinazzi C; Inama G
G Ital Cardiol (Rome); 2008 Oct; 9(10 Suppl 1):5S-10S. PubMed ID: 19195299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
